Protocol Ledger

NCT05727891 · Phase II · ACTIVE NOT RECRUITING

Evaluation of Tonabersat for DME

Interventional Phase II clinical trial protocol NCT05727891 sponsored by Jaeb Center for Health Research in Endocrinology, Obesity, and Metabolic, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2023-05-02 Enrollment: 128 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT05727891
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)128 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)1 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT05727891
Protocol FieldVerified Registry Value
NCT IdentifierNCT05727891
Consolidated Lead SponsorJaeb Center for Health Research
Therapeutic Condition CohortEndocrinology, Obesity, and Metabolic
Clinical Trial PhasePhase II
Overall Recruitment StatusACTIVE NOT RECRUITING
Registered Enrollment128 participants (ESTIMATED)
Registered Start Date2023-05-02
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Listed on NCT05727891
Hospital Research SiteLocationSite Profile
Loma Linda University Medical CenterLoma Linda, CAOpen Hospital Dossier ->

Search related sites and sponsors in the Interactive Directory, explore Endocrinology, Obesity, and Metabolic Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI